Dr Stella Xu
Board Member
Member of the Board of Directors since 2020, Member of the Compensation and of the Nominating Committees, US national
Career
Ph.D. in Immunology from Northwestern University and B.Sc. in Biophysics from Peking University; since 2017 managing director of Quan Capital. Previously at Roche (2002 to 2017), McKinsey & Company (1998 to 2002) and Inois Pharmaceuticals (1996 to 1998).
Directorships
Member of the Board of Directors of Therorna since 2021, Design Therapeutics since 2020, Walking Fish Therapeutics since 2019 and Zidan Medical since 2018.
